Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 4
1948 2
1950 2
1951 3
1952 6
1953 6
1954 5
1955 1
1956 6
1957 12
1958 1
1959 3
1961 3
1962 2
1963 4
1965 5
1966 4
1967 4
1968 4
1969 7
1970 2
1971 1
1972 3
1973 3
1974 5
1975 2
1976 1
1977 3
1978 3
1979 3
1980 1
1981 2
1982 2
1983 2
2001 2
2002 1
2003 2
2004 1
2005 1
2006 1
2007 1
2008 1
2017 1
2018 1
2019 2
2022 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
Lebrun-Frénay C, Siva A, Sormani MP, Landes-Chateau C, Mondot L, Bovis F, Vermersch P, Papeix C, Thouvenot E, Labauge P, Durand-Dubief F, Efendi H, Le Page E, Terzi M, Derache N, Bourre B, Hoepner R, Karabudak R, De Seze J, Ciron J, Clavelou P, Wiertlewski S, Turan OF, Yucear N, Cohen M, Azevedo C, Kantarci OH, Okuda DT, Pelletier D; TERIS Study Group. Lebrun-Frénay C, et al. JAMA Neurol. 2023 Oct 1;80(10):1080-1088. doi: 10.1001/jamaneurol.2023.2815. JAMA Neurol. 2023. PMID: 37603328 Free PMC article. Clinical Trial.
Chemokine inhibition--why, when, where, which and how?
Johnson Z, Power CA, Weiss C, Rintelen F, Ji H, Ruckle T, Camps M, Wells TN, Schwarz MK, Proudfoot AE, Rommel C. Johnson Z, et al. Among authors: rintelen f. Biochem Soc Trans. 2004 Apr;32(Pt 2):366-77. doi: 10.1042/bst0320366. Biochem Soc Trans. 2004. PMID: 15046611 Review.
[For partial tenotomy].
RINTELEN F. RINTELEN F. Ophthalmologica. 1956 Apr-May;131(4-5):254-6. doi: 10.1159/000302828. Ophthalmologica. 1956. PMID: 13335097 German. No abstract available.
[Ophtalmoneurology].
Rintelen F. Rintelen F. Med Welt. 1977 Mar 4;28(9):403-7. Med Welt. 1977. PMID: 846378 German. No abstract available.
[Ocular tuberculosis].
RINTELEN F. RINTELEN F. Bibl Tuberc. 1954;7:287-300. Bibl Tuberc. 1954. PMID: 13172157 Undetermined Language. No abstract available.
Booster-free anti-retroviral therapy for persons living with HIV and multidrug resistance (B-Free): protocol for a multicentre, multistage, randomised, controlled, non-inferiority trial.
Ballif M, Braun D, Calmy A, Bernasconi E, Cavassini M, Tissot F, Stoeckle M, Schmid P, Fux CA, Van der Valk M, Brinkman K, Mudrikova T, Bonnet F, Leleux O, Saúde M, Hirter D, Schwab N, Limacher A, Rintelen F, Kouyos R, Haerry D, Zambrano SC, Egloff M, Akre C, Peytremann-Bridevaux I, Rauch A, Wandeler G, Surial B. Ballif M, et al. Among authors: rintelen f. BMJ Open. 2024 Nov 21;14(11):e094912. doi: 10.1136/bmjopen-2024-094912. BMJ Open. 2024. PMID: 39578038 Free PMC article.
[Diamox therapy of glaucoma].
RINTELEN F, JENNY E. RINTELEN F, et al. Ophthalmologica. 1955 Sep;130(3):171-7. doi: 10.1159/000302670. Ophthalmologica. 1955. PMID: 13266317 German. No abstract available.
[Eye fundus in hypertension].
RINTELEN F. RINTELEN F. Ophthalmologica. 1958 May-Jun;135(5-6):389-404. doi: 10.1159/000303331. Ophthalmologica. 1958. PMID: 13553253 German. No abstract available.
136 results